AI Engines For more Details: Perplexity Kagi Labs You
Research Tool: Gabazine bromide is primarily used as a pharmacological tool in scientific research to study the function of GABAA receptors and the role of inhibitory neurotransmission in the central nervous system. By blocking specific subtypes of GABAA receptors, gabazine bromide helps researchers investigate the physiological and pharmacological properties of these receptors and their implications for various neurological and psychiatric conditions.
Seizure Research: Since GABAA receptors mediate inhibitory neurotransmission and play a role in the regulation of neuronal excitability, gabazine bromide is often used in experimental models of epilepsy and seizure disorders. By blocking GABAA receptors, gabazine bromide can induce seizure-like activity in animal models, allowing researchers to study the mechanisms underlying seizures and explore potential antiepileptic drugs.
Neurological Disorders: While gabazine bromide itself is not used clinically to treat neurological disorders, research involving this compound has contributed to our understanding of the pathophysiology of conditions such as epilepsy, anxiety disorders, and neuropathic pain. Insights gained from studies using gabazine bromide may inform the development of novel therapeutic strategies targeting GABAA receptors for the management of these disorders.
Pharmacological Studies: Gabazine bromide is also used in pharmacological studies to investigate the effects of GABAA receptor antagonism on behavior, cognition, and neurotransmitter systems. By modulating GABAA receptor activity, gabazine bromide can alter synaptic transmission and neuronal excitability, leading to changes in animal behavior and cognitive function. These studies help elucidate the role of GABAA receptors in normal brain function and their involvement in neuropsychiatric conditions.
Drug Development: Insights gained from research involving gabazine bromide may have implications for the development of new therapeutic agents targeting GABAA receptors. By identifying specific receptor subtypes involved in various neurological disorders, researchers can design more selective drugs with improved efficacy and fewer side effects compared to non-selective GABAA receptor antagonists like gabazine bromide.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Romboutsia sp. 13368 | species | Decreases |
0 | 1 | Dysosmobacter welbionis | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.1 | 0.1 | |
Acne | 0.4 | -0.4 | |
ADHD | 3.2 | 0.6 | 4.33 |
Age-Related Macular Degeneration and Glaucoma | 0.9 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 2.1 | 2.8 | -0.33 |
Allergies | 5.4 | 2.3 | 1.35 |
Allergy to milk products | 1.3 | 0.9 | 0.44 |
Alopecia (Hair Loss) | 1.1 | 0.1 | 10 |
Alzheimer's disease | 3.5 | 4.7 | -0.34 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.7 | 0.6 | 1.83 |
Ankylosing spondylitis | 2.6 | 0.8 | 2.25 |
Anorexia Nervosa | 1.2 | 1.9 | -0.58 |
Antiphospholipid syndrome (APS) | 0.5 | 0.5 | |
Asthma | 4.1 | 2.4 | 0.71 |
Atherosclerosis | 1.7 | 1.2 | 0.42 |
Atrial fibrillation | 2.1 | 0.8 | 1.63 |
Autism | 6.3 | 5.3 | 0.19 |
Autoimmune Disease | 0.6 | 0.9 | -0.5 |
Barrett esophagus cancer | 0.3 | 0.1 | 2 |
benign prostatic hyperplasia | 0.1 | 0.2 | -1 |
Biofilm | 1.3 | 1.3 | |
Bipolar Disorder | 0.8 | 1.1 | -0.38 |
Brain Trauma | 1.1 | 1.2 | -0.09 |
Breast Cancer | 0.1 | 0.1 | |
Cancer (General) | 0.5 | 2.3 | -3.6 |
Carcinoma | 2.5 | 2 | 0.25 |
Celiac Disease | 1.7 | 2.9 | -0.71 |
Cerebral Palsy | 1.2 | 1.2 | 0 |
Chronic Fatigue Syndrome | 4 | 4 | 0 |
Chronic Kidney Disease | 3.4 | 2.3 | 0.48 |
Chronic Lyme | 0.5 | 0.6 | -0.2 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.1 | 1 | 0.1 |
Chronic Urticaria (Hives) | 0.7 | 0.4 | 0.75 |
Coagulation / Micro clot triggering bacteria | 0.4 | 1.1 | -1.75 |
Cognitive Function | 1.6 | 1.2 | 0.33 |
Colorectal Cancer | 3.3 | 1.9 | 0.74 |
Constipation | 0.6 | 0.8 | -0.33 |
Coronary artery disease | 1.6 | 2.1 | -0.31 |
COVID-19 | 7.3 | 9.5 | -0.3 |
Crohn's Disease | 4 | 3.8 | 0.05 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.2 | 2 | -9 |
d-lactic acidosis (one form of brain fog) | 0.3 | 0.3 | |
deep vein thrombosis | 0.5 | 0.9 | -0.8 |
Denture Wearers Oral Shifts | 1.1 | 1.1 | |
Depression | 6.8 | 6.8 | 0 |
Dermatomyositis | 0.1 | 0.4 | -3 |
Eczema | 0.9 | 1.5 | -0.67 |
Endometriosis | 1.6 | 1.4 | 0.14 |
Eosinophilic Esophagitis | 0.4 | -0.4 | |
Epilepsy | 2.2 | 1.4 | 0.57 |
erectile dysfunction | 0.3 | 0.4 | -0.33 |
Fibromyalgia | 2.3 | 0.8 | 1.87 |
Functional constipation / chronic idiopathic constipation | 2.8 | 2.6 | 0.08 |
gallstone disease (gsd) | 1.9 | 1 | 0.9 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | 1.6 | -4.33 |
Generalized anxiety disorder | 1.6 | 1.6 | 0 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.1 | -0.1 | |
Gout | 1.5 | 0.2 | 6.5 |
Graves' disease | 1.5 | 2.8 | -0.87 |
Gulf War Syndrome | 0.6 | 0.9 | -0.5 |
Halitosis | 0.6 | 0.1 | 5 |
Hashimoto's thyroiditis | 3.1 | 1.5 | 1.07 |
Heart Failure | 1.9 | 1.9 | 0 |
hemorrhagic stroke | 0.3 | 0.3 | |
Hidradenitis Suppurativa | 0.5 | 0.3 | 0.67 |
High Histamine/low DAO | 0.8 | 0.6 | 0.33 |
hypercholesterolemia (High Cholesterol) | 0.4 | 0.4 | 0 |
hyperglycemia | 1.1 | 1.4 | -0.27 |
Hyperlipidemia (High Blood Fats) | 1 | 0.4 | 1.5 |
hypersomnia | 0.8 | -0.8 | |
hypertension (High Blood Pressure | 3.2 | 4.5 | -0.41 |
Hypothyroidism | 0.1 | 1 | -9 |
Hypoxia | 1.2 | 1.2 | |
IgA nephropathy (IgAN) | 0.7 | 3 | -3.29 |
Inflammatory Bowel Disease | 5.7 | 7 | -0.23 |
Insomnia | 1.7 | 2.4 | -0.41 |
Intelligence | 0.6 | 0.6 | |
Intracranial aneurysms | 0.7 | 0.4 | 0.75 |
Irritable Bowel Syndrome | 5.1 | 3.1 | 0.65 |
ischemic stroke | 2.4 | 0.8 | 2 |
Liver Cirrhosis | 4.7 | 2.6 | 0.81 |
Long COVID | 4.5 | 6.5 | -0.44 |
Low bone mineral density | 0.9 | -0.9 | |
Lung Cancer | 0.3 | 1.3 | -3.33 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.2 | 0.6 | -2 |
ME/CFS with IBS | 0.4 | 2.5 | -5.25 |
ME/CFS without IBS | 1.4 | 1.6 | -0.14 |
membranous nephropathy | 0.1 | 0.1 | |
Menopause | 2.3 | 0.7 | 2.29 |
Metabolic Syndrome | 4.8 | 5.6 | -0.17 |
Mood Disorders | 7.4 | 5.6 | 0.32 |
multiple chemical sensitivity [MCS] | 0.8 | 0.4 | 1 |
Multiple Sclerosis | 4.7 | 3.3 | 0.42 |
Multiple system atrophy (MSA) | 1.3 | 0.9 | 0.44 |
myasthenia gravis | 0.2 | 0.5 | -1.5 |
neuropathic pain | 0.2 | 2.1 | -9.5 |
Neuropathy (all types) | 0.9 | 0.9 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.6 | 4.7 | -0.31 |
NonCeliac Gluten Sensitivity | 1.9 | 0.6 | 2.17 |
Obesity | 8 | 5.9 | 0.36 |
obsessive-compulsive disorder | 3.4 | 2.8 | 0.21 |
Osteoarthritis | 1.8 | 1.2 | 0.5 |
Osteoporosis | 1.5 | 1.5 | 0 |
pancreatic cancer | 0.3 | 0.1 | 2 |
Parkinson's Disease | 6.4 | 4.7 | 0.36 |
Polycystic ovary syndrome | 3.2 | 2.5 | 0.28 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.4 | -3 |
Premenstrual dysphoric disorder | 1.2 | 0 | 0 |
primary biliary cholangitis | 0.7 | 0.6 | 0.17 |
Primary sclerosing cholangitis | 1.8 | 1.9 | -0.06 |
Psoriasis | 2.9 | 1.1 | 1.64 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5.7 | 2.9 | 0.97 |
Rosacea | 1.2 | 0.5 | 1.4 |
Schizophrenia | 5.3 | 2.2 | 1.41 |
scoliosis | 0.3 | 0.5 | -0.67 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 1.8 | 1.9 | -0.06 |
Sleep Apnea | 1.2 | 1.2 | 0 |
Slow gastric motility / Gastroparesis | 0.8 | 0.4 | 1 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.9 | 0.7 | 0.29 |
Stress / posttraumatic stress disorder | 1.6 | 2.2 | -0.38 |
Systemic Lupus Erythematosus | 2 | 2.4 | -0.2 |
Tic Disorder | 0.5 | 1.4 | -1.8 |
Tourette syndrome | 0.5 | 0.2 | 1.5 |
Type 1 Diabetes | 2.2 | 3.3 | -0.5 |
Type 2 Diabetes | 5.2 | 3.9 | 0.33 |
Ulcerative colitis | 2.9 | 4 | -0.38 |
Unhealthy Ageing | 2.8 | 1.4 | 1 |
Vitiligo | 1.1 | 0.8 | 0.38 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]